Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
5.75
-0.16 (-2.71%)
At close: Dec 5, 2025, 4:00 PM EST
5.74
-0.01 (-0.17%)
After-hours: Dec 5, 2025, 6:15 PM EST
Karyopharm Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$22.17
Upside
+285.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $30 → $19 | Buy | Maintains | $30 → $19 | +230.43% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $15 | Hold → Strong Buy | Upgrades | $15 | +160.87% | Oct 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $15 → $12 | Buy | Reiterates | $15 → $12 | +108.70% | Oct 9, 2025 |
| Baird | Baird | Buy Maintains $25 → $21 | Buy | Maintains | $25 → $21 | +265.22% | Oct 9, 2025 |
| Baird | Baird | Buy Maintains $42 → $25 | Buy | Maintains | $42 → $25 | +334.78% | Aug 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +369.57% | Jul 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $34 → $33 | Buy | Maintains | $34 → $33 | +473.91% | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $10 | Buy | Maintains | $5 → $10 | +73.91% | May 13, 2025 |
| Baird | Baird | Buy Maintains $54 → $42 | Buy | Maintains | $54 → $42 | +630.43% | May 13, 2025 |
| Baird | Baird | Buy Maintains $75 → $54 | Buy | Maintains | $75 → $54 | +839.13% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $56 | Strong Buy | Maintains | $7 → $56 | +873.91% | Feb 26, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $45 | Buy | Reiterates | $45 | +682.61% | Feb 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +1,726.09% | Feb 20, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $45 | Buy | Reiterates | $45 | +682.61% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +1,726.09% | Jan 15, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.